These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

179 related items for PubMed ID: 1687773

  • 1. Irreversible blockade of the kappa-receptor by a newly synthesized dynorphin derivative containing a 3-nitro-2-pyridinesulfenyl group.
    Koike K, Takayanagi I, Hirakura Y, Matsueda R.
    Arch Int Pharmacodyn Ther; 1991; 313():33-46. PubMed ID: 1687773
    [Abstract] [Full Text] [Related]

  • 2. Evidence that dynorphin-(1-13) acts as an agonist on opioid kappa-receptors.
    Oka T, Negishi K, Suda M, Sawa A, Fujino M, Wakimasu M.
    Eur J Pharmacol; 1982 Jan 22; 77(2-3):137-41. PubMed ID: 6277659
    [Abstract] [Full Text] [Related]

  • 3. Comparison of dynorphin-selective Kappa receptors in mouse vas deferens and guinea pig ileum. Spare receptor fraction as a determinant of potency.
    Cox BM, Chavkin C.
    Mol Pharmacol; 1983 Jan 22; 23(1):36-43. PubMed ID: 6135144
    [No Abstract] [Full Text] [Related]

  • 4. The choice of opioid receptor subtype in isolated preparations by dynorphins.
    Oka T, Aoki K, Kajiwara M.
    Life Sci; 1983 Jan 22; 33 Suppl 1():311-4. PubMed ID: 6141492
    [Abstract] [Full Text] [Related]

  • 5. Dynorphin A(1-8): stability and implications for in vitro opioid activity.
    Bell KM, Traynor JR.
    Can J Physiol Pharmacol; 1998 Mar 22; 76(3):325-33. PubMed ID: 9673796
    [Abstract] [Full Text] [Related]

  • 6. Opioid profiles of Cys2-containing enkephalin analogues.
    Pencheva N, Milanov P, Vezenkov L, Pajpanova T, Naydenova E.
    Eur J Pharmacol; 2004 Sep 13; 498(1-3):249-56. PubMed ID: 15364002
    [Abstract] [Full Text] [Related]

  • 7. PD117302: a selective agonist for the kappa-opioid receptor.
    Clark CR, Birchmore B, Sharif NA, Hunter JC, Hill RG, Hughes J.
    Br J Pharmacol; 1988 Mar 13; 93(3):618-26. PubMed ID: 2836012
    [Abstract] [Full Text] [Related]

  • 8. Peptide models of dynorphin A(1-17) incorporating minimally homologous substitutes for the potential amphiphilic beta strand in residues 7-15.
    Taylor JW.
    Biochemistry; 1990 Jun 05; 29(22):5364-73. PubMed ID: 1974458
    [Abstract] [Full Text] [Related]

  • 9. Regulatory role of enteric mu and kappa opioid receptors in the release of acetylcholine and norepinephrine from guinea pig ileum.
    Nakayama S, Taniyama K, Matsuyama S, Ohgushi N, Tsunekawa K, Tanaka C.
    J Pharmacol Exp Ther; 1990 Sep 05; 254(3):792-8. PubMed ID: 1975621
    [Abstract] [Full Text] [Related]

  • 10. Dynorphin A-(1-13)-Tyr14-Leu15-Phe16-Asn17-Gly18-Pro19 : a potent and selective kappa opioid peptide.
    Martinka GP, Jhamandas K, Sabourin L, Lapierre C, Lemaire S.
    Eur J Pharmacol; 1991 Apr 17; 196(2):161-7. PubMed ID: 1678718
    [Abstract] [Full Text] [Related]

  • 11. Interaction of newly synthesized N-cyclopropylmethyl derivatives of (-)-6 beta-acetylthionormorphine with opioid receptors.
    Takayanagi I, Goromaru N, Koike K, Konno F, Mori T, Yoshida M, Kanematsu K.
    Gen Pharmacol; 1990 Apr 17; 21(4):541-6. PubMed ID: 2165960
    [Abstract] [Full Text] [Related]

  • 12. Analgesic, receptor binding, and peripheral opioid activities of synthetic dermorphin-dynorphin hybrid peptides.
    Ho CL, Ko JL, Hwang LL, Wang KT.
    Int J Pept Protein Res; 1990 Feb 17; 35(2):99-104. PubMed ID: 1969854
    [Abstract] [Full Text] [Related]

  • 13. Intrinsic activity and effects of guanyl-5'-yl imidodiphosphate, Gpp(NH)p and sodium ion on the affinity of dynorphin 1-13, nalorphine and nalorphine-7,8-oxide to kappa-opioid receptor.
    Takayanagi I, Okumura K, Konno F, Koike K, Cho N, Hirobe M.
    Gen Pharmacol; 1985 Feb 17; 16(6):617-9. PubMed ID: 2867951
    [Abstract] [Full Text] [Related]

  • 14. Kappa opioid properties of dynorphin and its peptide fragments on the guinea-pig Ileum.
    Yoshimura K, Huidobro-Toro JP, Lee NM, Löh HH, Way EL.
    J Pharmacol Exp Ther; 1982 Jul 17; 222(1):71-9. PubMed ID: 6123594
    [No Abstract] [Full Text] [Related]

  • 15. 14-beta-Methyl-8-oxacyclorphan (BC-3016), a morphinan derivative with high affinity for kappa opioid receptor: comparison with dynorphin-A(1-13).
    Lemaire S, Dumont M, Jolicoeur F, Belleau B.
    Can J Physiol Pharmacol; 1986 Jun 17; 64(6):707-11. PubMed ID: 2875779
    [Abstract] [Full Text] [Related]

  • 16. Comparative effects of dynorphin A(1-9) pyrrolidine analogs on isolated tissues.
    Rezvani A, Kadambi SR, Rhoads DL, Chang JK, Way EL.
    NIDA Res Monogr; 1986 Jun 17; 75():228-31. PubMed ID: 2893265
    [Abstract] [Full Text] [Related]

  • 17. Beta-endorphin. Biological activity of analogs containing dermorphin and dynorphin sequences: ileum and vas deferens assays.
    Ho CL, Li CH.
    Int J Pept Protein Res; 1987 Jan 17; 29(1):134-9. PubMed ID: 2883148
    [Abstract] [Full Text] [Related]

  • 18. Comparison of the action of putative endogenous kappa-agonists, leumorphin and rimorphin in vitro.
    Suda M, Nakao K, Yoshimasa T, Ikeda Y, Sakamoto M, Yanaihara C, Yanaihara N, Numa S, Imura H.
    Life Sci; 1983 Jan 17; 33 Suppl 1():275-8. PubMed ID: 6319876
    [Abstract] [Full Text] [Related]

  • 19. Opioid receptor activity of GI 87084B, a novel ultra-short acting analgesic, in isolated tissues.
    James MK, Feldman PL, Schuster SV, Bilotta JM, Brackeen MF, Leighton HJ.
    J Pharmacol Exp Ther; 1991 Nov 17; 259(2):712-8. PubMed ID: 1658308
    [Abstract] [Full Text] [Related]

  • 20. Photoaffinity labeling of opioid receptor with morphine-7,8-oxide (morphine epoxide).
    Takayanagi I, Shibata R, Miyata N, Hirobe M.
    J Pharmacol Methods; 1982 May 17; 7(3):185-92. PubMed ID: 6287114
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.